Scott Peter Jh, Penuelas Ivan, Rey Ana, Aime Silvio, Ambikalmajan Pillai M R, Antunes Ines Farinha, Cleeren Frederik, Liu Zhaofei, Ellis Beverley, Kahts Maryke, Ekoume Fany Pricile, Chaple Ivis F, Bernardes Emerson, Behe Martin, Huang Ya-Yao, Mikolajczak Renata, Furumoto Shozo, Elrefaei Amal, Kopka Klaus
University of Michigan, Ann Arbor, MI, USA.
University Clinic of Navarra, Pamplona, Spain.
EJNMMI Radiopharm Chem. 2024 Sep 16;9(1):67. doi: 10.1186/s41181-024-00296-6.
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
This selection of highlights provides commentary on 19 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.
Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
《EJNMMI放射药学与化学》编辑委员会每半年发布一次重点评论,向读者介绍放射性药物开发领域的趋势。
本精选重点内容由每位共同撰写的编辑委员会成员选择了19个不同主题进行评论,涵盖从新型放射化学到新型放射性药物首次人体应用等各个方面。
突出了放射化学和放射药学的趋势。热门话题涵盖了《EJNMMI放射药学与化学》的整个范围,展示了该研究领域在许多方面的进展。